Home Authors Posts by Joshua Mansour, M.D.

Joshua Mansour, M.D.

Joshua Mansour, M.D.
3 POSTS 0 COMMENTS
Dr. Joshua Mansour received his undergraduate degree from Vanderbilt University where he was a chancellor scholar. He then went on to Ross University School of Medicine to continue his education.

Dr. Mansour recently received Ross University School of Medicine 2019 Early Distinguished Career Award, given to a “young alumni” that has already experienced a high level of success and displayed promise for future growth and leadership opportunities.

He completed his internal medicine residency at Medical College of Georgia, completed a fellowship in Hematology and Oncology at the Medical University of South Carolina, and then went to Stanford University to pursue an additional fellowship in Bone Marrow Transplantation and Cellular Immunotherapy. He is triple board certified in internal medicine, hematology, and oncology.

Dr. Mansour actively belongs to several associations including the Medical Oncology Association of Southern California, where he is currently a board member, the California Medical Association, American Society of Clinical Oncology, the Community Oncology Association, where he is on the CAR T-Cell Task Force, American Society of Hematology, and American Society of Transplantation & Cellular therapy. He also serves as a physician mentor for students as part of the American College of Physicians.

Although he has an extensive and varied medical background and training, he currently focuses on hematological malignancies. He is a bone marrow transplant and cellular immunotherapy physician in Los Angeles, CA. This is where he sees patients, continues research in this field, as well as helping with clinical trials.

He dedicates much of his spare time investigating ways to improve patient care and outcomes. He has helped design and implement clinical studies to evaluate current treatment plans, collaborated on grant proposals, and lead multi-institutional retrospective studies that have been published in major high impact medical and scientific journals.

In addition to these studies, he has been writing for several years. His commentaries and pieces have been published in several outlets including US News & World Report, Cancer Therapy Advisor, DrugWatch, Today’s Practioner, KevinMD, and Physician’s News. Dr. Mansour has also been featured on FOX television among other media outlets.

Most recently he was the recipient of the “40 under 40 in Cancer” Award. This award is given to recognize the contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40. Recipients are selected by a panel of reviewers from across diverse roles in oncology.

artificial intelligence cancer screening

Artificial Intelligence: Can It Improve Results of Cancer Screening Programs?

2
Breast & lung cancer screening programs have led to diagnoses at an earlier stage. AI-deep learning systems improve on those results by reducing diagnostic errors.
laser detect cancer

Research: New Laser Tech Can Detect Circulating Cancer Cells

0
A small study demonstrates that a new laser tech can detect circulating cancer cells in melanoma patients at levels far more sensitive than currently available technologies.
CAR T-cell therapy cancer

CAR T-Cell Therapy for Cancer: What’s New on the Road to Cure?

0
Even though CAR T-cell therapy is not well known to the general public, it has been speeding along the medical highway with no rest stop in sight.